Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 21 patents
16 readers on Mendeley
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114304

Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.

J Satoh, H Seino, T Abo, S Tanaka, S Shintani, S Ohta, K Tamura, T Sawai, T Nobunaga, and T Oteki

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Satoh, J. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Seino, H. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Abo, T. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Tanaka, S. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Shintani, S. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Ohta, S. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Tamura, K. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Sawai, T. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Nobunaga, T. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Find articles by Oteki, T. in: JCI | PubMed | Google Scholar

Published October 1, 1989 - More info

Published in Volume 84, Issue 4 on October 1, 1989
J Clin Invest. 1989;84(4):1345–1348. https://doi.org/10.1172/JCI114304.
© 1989 The American Society for Clinical Investigation
Published October 1, 1989 - Version history
View PDF
Abstract

We previously reported that administration of a streptococcal preparation (OK-432) inhibited insulitis and development of autoimmune diabetes in nonobese diabetic (NOD) mice and BB rats as animals models of insulin-dependent diabetes mellitus. In this study, we screened various cytokines that could be induced by OK-432 in vivo, for their preventive effect against diabetes in NOD mice. Among recombinant mouse IFN gamma, human IL1 alpha, human IL2, mouse granulocyte-macrophage colony-stimulating factor and human TNF alpha, only human TNF alpha suppressed insulitis and significantly (P less than 0.001) inhibited development of diabetes. NOD mice were the lowest producers of the mRNA of TNF and serum TNF on stimulation with OK-432 or with IFN gamma plus LPS, compared with C57BL/6, C3H/He, and Balb/c mice. The results imply a role for low productivity of TNF in the pathogenesis of autoimmune diabetes in NOD mice.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1345
page 1345
icon of scanned page 1346
page 1346
icon of scanned page 1347
page 1347
icon of scanned page 1348
page 1348
Version history
  • Version 1 (October 1, 1989): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 21 patents
16 readers on Mendeley
See more details